Zobrazeno 1 - 10
of 161
pro vyhledávání: '"gastro-oesophageal cancer"'
Autor:
Lyn Ley Lam, Nick Pavlakis, Kohei Shitara, Katrin M. Sjoquist, Andrew J. Martin, Sonia Yip, Yoon-Koo Kang, Yung-Jue Bang, Li-Tzong Chen, Markus Moehler, Tanios Bekaii-Saab, Thierry Alcindor, Christopher J. O’Callaghan, Niall C. Tebbutt, Wendy Hague, Howard Chan, Sun Young Rha, Keun-Wook Lee, Val Gebski, Anthony Jaworski, John Zalcberg, Timothy Price, John Simes, David Goldstein
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Advanced gastro-oesophageal cancer (AGOC) carries a poor prognosis. No standard of care treatment options are available after first and second-line therapies. Regorafenib is an oral multi-targeted tyrosine kinase inhibitor targeti
Externí odkaz:
https://doaj.org/article/b8e8b11dcadf410b83fe55a98f0861f4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Amy R. Sharkey, Bert-Ram Sah, Samuel J. Withey, Shaheel Bhuva, Radhouene Neji, Sami Jeljeli, Adrian Green, Gary J. R. Cook, Vicky Goh, On behalf of the Guy’s & St Thomas’ Oesophago-Gastric Research Group
Publikováno v:
European Journal of Hybrid Imaging, Vol 5, Iss 1, Pp 1-13 (2021)
Abstract Background 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) may improve cancer staging by combining sensitive cancer detection with high-contrast resolution and detail. We compared the diagnost
Externí odkaz:
https://doaj.org/article/92f412bce52d4f839f08b8ac3d1dc224
Autor:
Filip Van Herpe, Eric Van Cutsem
Publikováno v:
Cancers, Vol 15, Iss 7, p 1976 (2023)
Gastric cancer (GC) is an important cause of cancer worldwide with over one million new cases yearly. The vast majority of cases present in stage IV disease, and it still bears a poor prognosis. However, since 2010, progress has been made with the in
Externí odkaz:
https://doaj.org/article/3226b58b34cc4b258f510a6dc7b0a3e4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Irene Y. Chong, Naureen Starling, Alistair Rust, John Alexander, Lauren Aronson, Marta Llorca-Cardenosa, Ritika Chauhan, Asif Chaudry, Sacheen Kumar, Kerry Fenwick, Ioannis Assiotis, Nik Matthews, Ruwaida Begum, Andrew Wotherspoon, Monica Terlizzo, David Watkins, Ian Chau, Christopher J. Lord, Syed Haider, Sheela Rao, David Cunningham
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 2, p 215 (2021)
1. Background: The application of massively parallel sequencing has led to the identification of aberrant druggable pathways and somatic mutations within therapeutically relevant genes in gastro-oesophageal cancer. Given the widespread use of formali
Externí odkaz:
https://doaj.org/article/915bb413902f4856b83979729b3dfa2c
Autor:
Van Herpe, Filip, Van Cutsem, Eric
Publikováno v:
Cancers. 15:1976
Gastric cancer (GC) is an important cause of cancer worldwide with over one million new cases yearly. The vast majority of cases present in stage IV disease, and it still bears a poor prognosis. However, since 2010, progress has been made with the in
Autor:
Rob H.A. Verhoeven, Nadia Haj Mohammad, Laurens V. Beerepoot, Marije Slingerland, Willemieke P M Dijksterhuis, Merel J. M. van Velzen, Hanneke W. M. van Laarhoven, Theo van Voorthuizen, Marieke Pape, Geert-Jan Creemers, Sarah Derks
Publikováno v:
European Journal of Cancer, 156, 60-69. Elsevier Limited
van Velzen, M J M, Pape, M, Dijksterhuis, W P M, Slingerland, M, van Voorthuizen, T, Beerepoot, L V, Creemers, G-J, Derks, S, Mohammad, N H, Verhoeven, R H A & van Laarhoven, H W M 2021, ' The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer ', European Journal of Cancer, vol. 156, pp. 60-69 . https://doi.org/10.1016/j.ejca.2021.07.026
European Journal of Cancer, 156, 60-69. ELSEVIER SCI LTD
European Journal of Cancer, 156, 60-69. Pergamon
van Velzen, M J M, Pape, M, Dijksterhuis, W P M, Slingerland, M, van Voorthuizen, T, Beerepoot, L V, Creemers, G-J, Derks, S, Mohammad, N H, Verhoeven, R H A & van Laarhoven, H W M 2021, ' The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer ', European Journal of Cancer, vol. 156, pp. 60-69 . https://doi.org/10.1016/j.ejca.2021.07.026
European Journal of Cancer, 156, 60-69. ELSEVIER SCI LTD
European Journal of Cancer, 156, 60-69. Pergamon
Background: Population-based predictive factors for the effectiveness of second line palliative systemic therapy in gastro-oesophageal cancer are not available. This study investigates the predictive value of effectiveness of first-line treatment for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96add93c6614c61ead7a93057b3728af
https://pure.amc.nl/en/publications/the-association-between-effectiveness-of-firstline-treatment-and-secondline-treatment-in-gastrooesophageal-cancer(f6e8eee6-f7c5-43c4-ae29-1409af9d288a).html
https://pure.amc.nl/en/publications/the-association-between-effectiveness-of-firstline-treatment-and-secondline-treatment-in-gastrooesophageal-cancer(f6e8eee6-f7c5-43c4-ae29-1409af9d288a).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P. Auvinen, Raija Ristamäki, Eija Korkeila, Raija Kallio, M. Mikkola, T. Salminen, Seppo Pyrhönen
Publikováno v:
Supportive Care in Cancer
This study aimed to evaluate the feasibility and tolerability of biweekly docetaxel with capecitabine as first-line treatment in advanced gastro-oesophageal cancer. Fifty-three patients at median age of 61 years with advanced gastric cancer were incl